Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease
about
A cluster randomized trial to assess the impact of opinion leader endorsed evidence summaries on improving quality of prescribing for patients with chronic cardiovascular disease: rationale and design [ISRCTN26365328]A randomized trial to assess the impact of opinion leader endorsed evidence summaries on the use of secondary prevention strategies in patients with coronary artery disease: the ESP-CAD trial protocol [NCT00175240]How equitable are GP practice prescribing rates for statins?: an ecological study in four primary care trusts in North West EnglandScreening for diabetes in general practice: cross sectional population studyThe gender specific frequency of risk factor and CHD diagnoses prior to incident MI: a community study.Cardiovascular medication utilization and adherence among adults living in rural and urban areas: a systematic review and meta-analysis.Cholesterol risk management: a systematic examination of the gap from evidence to practice.Ambulatory hypercholesterolemia management in patients with atherosclerosis. Gender and race differences in processes and outcomes.Review of evidence and explanations for suboptimal screening and treatment of dyslipidemia in women. A conceptual model.Use of cholesterol-lowering therapy and related beliefs among middle-aged adults after myocardial infarctionHMG coenzyme A reductase inhibitors: good news and bad news.Quality of care of patients hospitalized with acute coronary syndromes.Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort studyEstimating the impact of adding C-reactive protein as a criterion for lipid lowering treatment in the United StatesWho receives lipid-lowering drugs: the effects of comorbidities and patient characteristics on treatment initiation.Association between adherence to statin therapy and lipid control in Hong Kong Chinese patients at high risk of coronary heart disease.Drug development and use in the elderly: search for the right dose and dosing regimen (Parts I and II).Cost of a pharmacist-directed intervention to increase treatment of hypercholesterolemia.Achieving National Cholesterol Education Program goals in coronary artery disease.Changing trends (1986-2003) in the use of lipid lowering medication in patients hospitalized with acute myocardial infarction: a community-based perspective.Are patients with hyperlipidemia undertreated? Study of patients admitted to hospital with coronary events.The clinical effect and tolerability of ezetimibe in high-risk patients managed in a specialty cardiovascular risk reduction clinic.Maintenance of improved lipid levels following attendance at a cardiovascular risk reduction clinic: a 10-year experienceStatins: underused by those who would benefitEconomic impact of community pharmacist intervention in cholesterol risk management: an evaluation of the study of cardiovascular risk intervention by pharmacists.Improving care to patients with ischemic heart disease: experiences in a single network of the Veterans Health Administration.Long-term impact of a community pharmacist intervention on cholesterol levels in patients at high risk for cardiovascular events: extended follow-up of the second study of cardiovascular risk intervention by pharmacists (SCRIP-plus).Preference-based instrumental variable methods for the estimation of treatment effects: assessing validity and interpreting results.
P2860
Q24811254-8093C9FB-D404-4290-A823-E6BD2812802AQ28218403-788AC167-2BFB-4A78-AB1E-C3DE87D5C81CQ28221444-25D01E6D-5732-4C3D-B896-FF65CF78B0C2Q28350346-B05C63EE-4CD3-4195-B05E-FD18A05805BEQ33281123-B6CDE2A2-8326-4451-828D-ACCC1FA28E7CQ33783232-E7714203-CA85-47A5-BA5E-94B2B493DA15Q34303364-34D9F9CA-08C2-416C-8F65-262D414DCC9CQ34722688-104CE8D6-C4D3-4A6A-A226-B9D0B54EEE02Q34742537-DDB1F2E3-4785-465A-9B86-62FE3236E6A5Q34742822-F47E3318-E68D-4E5D-B90A-81C6EDE0E387Q34751061-F4F1AB7D-4C59-4723-9CD6-FF9666AB8BA8Q34986797-520010A4-720A-4553-9C54-D37137EDBE54Q35128843-F50D27C9-40F9-4BFF-93DF-070F0B4C317BQ35683097-F341FDA9-B355-4F82-BD75-2308F0EFD715Q35825240-39038021-63B7-462C-B132-251E0EAC0796Q35826483-BF9EB060-AF09-4379-9B2A-83952993C472Q35826495-24224841-CA14-4B03-8F62-F547D2FCD846Q35875455-60E54129-8B3D-46A7-8BFB-7C4132A7E3D3Q36050068-7EDFEBE7-2D59-4A74-9C04-0237B92343B5Q36059776-708B5B71-E8F9-4161-8F2A-FC9B08E240B2Q36447582-2D284CC1-B633-46D1-AE28-E54D11C79AF6Q36943340-C2F32D71-DB23-45AC-9842-7834FDABE378Q37019934-6C2705BD-F7F0-4F00-83C7-915491CA58E6Q42768879-D5CB5C22-0AB9-4869-A090-459BB731E59FQ43605184-CBA4FD2E-5149-430D-A412-BED2217A101AQ45332539-6517C08F-CC0E-4F47-A95C-C19A253AB586Q46378376-64A3A497-A848-45D9-A7B3-FCCBA1387A3CQ53059318-D683E24A-88C9-43A7-B687-994CBA5D9304
P2860
Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease
@ast
Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease
@en
Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease
@nl
type
label
Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease
@ast
Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease
@en
Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease
@nl
prefLabel
Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease
@ast
Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease
@en
Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease
@nl
P2093
P2860
P1476
Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease
@en
P2093
J H Gurwitz
S B Soumerai
S R Majumdar
P2860
P304
P356
10.1046/J.1525-1497.1999.02229.X
P577
1999-12-01T00:00:00Z
P5875
P6179
1000265817